INTRA-ARTERIAL BCNU CHEMOTHERAPY FOR TREATMENT OF MALIGNANT GLIOMAS OF THE CENTRAL NERVOUS-SYSTEM

被引：133

作者：

GREENBERG, HS

ENSMINGER, WD

CHANDLER, WF

LAYTON, PB

JUNCK, L

KNAKE, J

VINE, AK

机构：

来源：

关键词：

D O I：

10.3171/jns.1984.61.3.0423

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：423 / 429

页数：7

共 24 条

[1] AVELLANOSA AM, 1979, P AM ASSOC CANC RES, V20, P384
[2] BLACKSHEAR P J, 1970, Surgical Forum (Chicago), V21, P136
[3] CRAFTS DC, 1976, CANCER TREAT REP, V60, P541
[4] DEWYS WD, 1973, CANCER CHEMOTH REP 1, V57, P33
[5] CRITICAL EVALUATION OF PRINCIPLES GOVERNING ADVANTAGES OF INTRA-ARTERIAL INFUSIONS
ECKMAN, WW
PATLAK, CS
FENSTERMACHER, JD
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (03): : 257 - 285
[6] FENSTERMACHER JD, 1977, CANCER TREAT REP, V61, P519
[7] GEBARSKI SS, 1984, AM J NEURORADIOL, V5, P55
[8] GREENBERG HS, 1981, CANCER TREAT REP, V65, P803
[9] HOCHBERG FH, 1983, NEUROLOGY S2, V33, P109
[10] LIMITATIONS OF HIGH-DOSE INTRA-ARTERIAL 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA (BCNU) CHEMOTHERAPY FOR MALIGNANT GLIOMAS
KAPP, J
VANCE, R
PARKER, JL
SMITH, RR
[J]. NEUROSURGERY, 1982, 10 (06) : 715 - 719